type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed with type 2 diabetes for at least 1 year according to the diabetes diagnostic criteria formulated by the World Health Organization, and have been hospitalized in the department of endocrinology for diabetes during the recruitment period; 2. Male or female residents aged 18-75 years; 3. HbA1c measured within 6 months before enrollment was 7.0%-10.0%, and has been received hypoglycemic therapy for at least 8-12 weeks before admission; 4. Willingness to cooperate with the physician in completing all examinations during hospitalization; 5. Lived in the catchment and have established health records for at least 6 months, and have no plans to move out at present; 6. Sign the informed consent and participate in the study voluntarily.
Exclusion criteria
Exclusion criteria: 1. Patients with type 1 diabetes, LADA, gestational diabetes, patients with extremely poor islet function (fasting C-peptide < 0.1ng/ml) and patients with special type of diabetes; 2. Patients with serious complications (such as Stage G5 of diabetic nephropathy, severe loss of vision or blindness due to diabetic retinopathy and patients without self-care ability due to diabetic foot amputation). 3. Patients who suffered from serious mental illness or late stage of other serious diseases (such as malignant tumors, acute cardiovascular disease (like stroke, myocardial infarction), serious liver insufficiency, patients with history of diabetic ketoacidosis, patients with alcohol or drug abuse or dependence and patients with a life expectancy of less than three years; 4. Patients used continuous glucose monitoring (CGM) in the past 3 months before this admission; 5. Patients with cognitive impairment, or patients unable to use mobile phones to answer calls.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in glycated haemoglobin (in the form of HbA1c); | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in fasting blood glucose;Blood lipids;Fasting C-peptide;Blood Pressure;BMI (Body Mass Index);Incidence of diabetic retinopathy;Renal function;Incidence of macrovascular complications(carotid, cardiovascular);Diabetes self-management ability scores;Depression scores;Diabetes distress scores;The diabetes empowerment scores;Diabetes social support scores;Use of health services for patients with diabetes; | — |
Countries
China
Contacts
Baoan Central Hospital of Shenzhen